References
- American Psychiatric Association Committee on Electroconvulsive Therapy. The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging 2nd edn. American Psychiatric Press, Washington, DC 2001
- Sackeim H A, Devanand D P, Nobler M S. Electroconvulsive therapy. Psychopharmacology: the fourth generation of progress, F Bloom, D Kupfer. Raven, New York 1995; 1123–1142
- Imlah N W, Ryan E, Harrington J A. The influence of antidepressant drugs on the response to electroconvulsive therapy and on subsequent relapse rates. Neuropsychopharmacology 1965; 4: 438–442
- Sackeim H A, Haskett R F, Mulsant B H, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. Journal of the American Medical Association 2001; 285: 1299–1307
- Price L H. Pharmacologic strategies in refractory depression. American Psychiatric Press Review of Psychiatry, A Tasman, S M Goldfinger, C A Kaufman. American Psychiatric Press, Washington, DC 1990; 9: 116–131
- Kasper S, Pletan Y, Solles A, Tournoux A. Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression: a summary of clinical trial results. International Clinical Psychopharmacology 1996; 11(Suppl. 4)35–39
- Spencer C M, Wilde M I. Milnacipran. A review of its use in depression. Drugs 1998; 56: 405–427
- Lopez-Ibor J, Guelfi J D, Pletan Y, Tournoux A, Prost J F. Milnacipran and selective serotonin reuptake inhibitors in major depression. International Clinical Psychopharmacology 1996; 11: 41–46